In the E.U., their commercial plan is to partner either through a pan-European partnership or regional partnerships. 50 countries and Not a single country partnered yet. Weird?
What do you mean by saying "yet to be seen, is whether IDA favorable results will land Keryx a partnership". The European label is already "expanded". Auryxia was approved for broad use, in both the pre-dialysis and dialysis settings.
From Sepy. 29 2014 PR:
"Approximately 230 subjects, who have previously had an inadequate response to ORAL iron supplements, will be randomized"
Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act
"...the total number of Biotie shares owned directly or through financial instruments by Seth Klarman and entities under his control was 15.89 per cent of Biotie's total number of shares and voting rights on November 26, 2015"
We are losing part of our 10 years data and marketing exclusivity every day. No strategy, no partner, ... just a plan?! Greg, get lost!